Product Images Pregabalin

This is a description of a medication named Pregabalin distributed as capsules in bottles containing 60 capsules each. Four different bottle variants are listed that specify the dosage of the medicine as 50mg. A lot number, an expiry date, and a packaged-by are also mentioned. It is a prescription drug to be used as directed only. The pharmacy program is mentioned, as is the ideal storing temperature range.*

The text provided is showing a table with headers "Percent of Patients Improved" and "Percent Improvement in Pain from Baseline". The data in the table are not very clear, but it seems to be related to the effectiveness of Pregabalin, a medication of 160 mg taken over three days, in reducing pain. However, due to some missing and unreadable characters, the information provided is not entirely available.*

This appears to be a chart or table displaying the percent of patients who experienced improvement in pain while taking different medications at various doses. The medications listed include "Pregatalin" and "Pregabain" at different doses, as well as "Pregabalin" at a specific dose. The chart also includes a measurement of percent improvement in pain from a baseline measurement. However, the formatting and errors make it difficult to accurately interpret the data.*

This document appears to be a chart or table showing the dosage of two medications, Fregabalin and Pregataiin, as well as a placebo, administered three times daily. The chart also shows the percentage of patients who improved while taking each medication, as well as the percentage of improvement in pain from baseline. It is not clear what the context or purpose of the chart is.*

This appears to be a table indicating estimated percentages of subjects without LTR (not sure what LTR stands for) in a study, with two groups labeled "Progabain" and "Placebo", and time points indicated in days. Not much context is given to further understand the significance of this data.*

The text shows a chart indicating the percentage of subjects who have improved in a certain period of time, from baseline to week 16. There are two groups compared, one who has taken pregabalin and the other who has taken a placebo. The percentage of subjects improved ranges from 100% to 280%.*

This appears to be a formula for calculating creatinine clearance (CLCT), which is an important measure of kidney function. The calculation involves subtracting the patient's age from 140, then multiplying that number by their weight in kilograms. The result is then multiplied by 0.85 for female patients. The final step is to multiply the product by the patient's serum creatinine level in milligrams per deciliter (mg/dL) and divide by 72. CLCT is commonly used to evaluate the severity of kidney disease and to determine dosages of medications that are cleared by the kidneys.*